Open letter: European Medicines Agency should remove barriers to access clinical trial data.
about
Published and unpublished evidence in coverage decision-making for pharmaceuticals in Europe: existing approaches and way forward.Sharing Public Health Research Data: Toward the Development of Ethical Data-Sharing Practice in Low- and Middle-Income SettingsEvidence-informed recommendations to reduce dissemination bias in clinical research: conclusions from the OPEN (Overcome failure to Publish nEgative fiNdings) project based on an international consensus meetingWhat incentives increase data sharing in health and medical research? A systematic review.
P2860
Open letter: European Medicines Agency should remove barriers to access clinical trial data.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Open letter: European Medicine ...... to access clinical trial data.
@ast
Open letter: European Medicine ...... to access clinical trial data.
@en
type
label
Open letter: European Medicine ...... to access clinical trial data.
@ast
Open letter: European Medicine ...... to access clinical trial data.
@en
prefLabel
Open letter: European Medicine ...... to access clinical trial data.
@ast
Open letter: European Medicine ...... to access clinical trial data.
@en
P2093
P50
P356
P1433
P1476
Open letter: European Medicine ...... to access clinical trial data.
@en
P2093
David Tovey
Richard Lehman
Tracey Brown
P356
10.1136/BMJ.G3768
P407
P577
2014-06-06T00:00:00Z